[Hyperbaric oxygen therapy after unilateral idiopathic sudden deafness]. | Canada Hyperbarics Skip to main content
Clinical Study HNO 2004

[Hyperbaric oxygen therapy after unilateral idiopathic sudden deafness].

Kessler R — HNO, 2004

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Based on five reported cases and a literature review, researchers suggested hyperbaric oxygen therapy (HBOT) as a timely treatment option for unilateral idiopathic sudden deafness.

What They Found

In the five reported cases, patients experienced improved hearing after receiving HBOT, following the failure of conventional therapies. This led researchers to advocate for the timely use of HBOT in all cases of unilateral idiopathic deafness.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

The study's primary limitation is its reliance on a small number of reported cases and a lack of a controlled study design.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 14740118
Year Published 2004
Journal HNO
MeSH Terms Adult; Audiometry, Pure-Tone; Female; Hearing Loss, Sudden; Hemodilution; Humans; Hydroxyethyl Starch Derivatives; Hyperbaric Oxygenation; Male; Middle Aged; Pentoxifylline; Prognosis; Retreatment; Treatment Failure

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.